KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Change in Accured Expenses (2016 - 2025)

CareDx (CDNA) has disclosed Change in Accured Expenses for 13 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 112.57% to $12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.3 million through Dec 2025, up 96.54% year-over-year, with the annual reading at -$3.3 million for FY2025, 96.54% up from the prior year.
  • Change in Accured Expenses hit $12.1 million in Q4 2025 for CareDx, up from $3.9 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $12.1 million in Q4 2025 to a low of -$96.5 million in Q4 2024.
  • Historically, Change in Accured Expenses has averaged -$4.7 million across 5 years, with a median of $1.9 million in 2021.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 3360.42% in 2021 and later crashed 4423.52% in 2025.
  • Year by year, Change in Accured Expenses stood at $8.0 million in 2021, then crashed by 70.43% to $2.4 million in 2022, then grew by 26.79% to $3.0 million in 2023, then crashed by 3325.18% to -$96.5 million in 2024, then surged by 112.57% to $12.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CDNA at $12.1 million in Q4 2025, $3.9 million in Q3 2025, and $4.8 million in Q2 2025.